nucleix.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://nucleix.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Using Epigenetics for Cancer Detection in Liquid Biopsy |
Description EpiCheck is a highly innovative product for detection of cancer in liquid biopsy samples, using a panel of various methylation
Keywords N/A
Server Information
WebSite nucleix faviconnucleix.com
Host IP 212.235.25.47
Location Israel
Related Websites
Site Rank
More to Explore
nucleix.com Valuation
US$4,350,163
Last updated: 2023-05-08 10:28:05

nucleix.com has Semrush global rank of 2,433,082. nucleix.com has an estimated worth of US$ 4,350,163, based on its estimated Ads revenue. nucleix.com receives approximately 501,942 unique visitors each day. Its web server is located in Israel, with IP address 212.235.25.47. According to SiteAdvisor, nucleix.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$4,350,163
Daily Ads Revenue US$4,016
Monthly Ads Revenue US$120,467
Yearly Ads Revenue US$1,445,593
Daily Unique Visitors 33,463
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
nucleix.com. A 3599 IP: 212.235.25.47
nucleix.com. NS 3600 NS Record: nypop.netvision.net.il.
nucleix.com. NS 3600 NS Record: dns.netvision.net.il.
nucleix.com. MX 3600 MX Record: 0 nucleix-com.mail.protection.outlook.com.
nucleix.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-08 10:28:05
Customer Area Home-Global Products Bladder EpiCheck Lung Epicheck Technology Clinical Media News Events Videos Company Patients Contact us Login Customer Area EARLY DETECTION IS KEY OUR TESTS AIM TO DETECT CANCER EARLIER – WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS fighting cancer by Early detection EARLY DETECTION IS KEY OUR TESTS AIM TO DETECT CANCER EARLIER – WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS fighting cancer by Early detection EARLY DETECTION IS KEY OUR TESTS AIM TO DETECT CANCER EARLIER – WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS fighting cancer by Early detection WE DEVELOP, MANUFACTURE AND MARKET NON-INVASIVE CANCER TESTS USING OUR UNIQUE TECHNOLOGY, PARTNERING WITH LEADING CENTERS AROUND THE WORLD Nucleix’s Bladder EpiCheck® Receives FDA 510(k) Clearance for Monitoring of Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence READ MORE B ladder EpiCheck® Bladder EpiCheck ® , CE-marked and available in Europe
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 29 Oct 2021 20:50:31 GMT
Server: Apache/2.4.37 (centos) OpenSSL/1.1.1g
Location: https://nucleix.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 200 OK
Date: Fri, 29 Oct 2021 20:50:31 GMT
Server: Apache/2.4.37 (centos) OpenSSL/1.1.1g
X-Powered-By: PHP/7.4.13
X-Pingback: https://nucleix.com/xmlrpc.php
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
Content-Type: text/html; charset=UTF-8
nucleix.com Whois Information
Domain Name: NUCLEIX.COM
Registry Domain ID: 1367842726_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.domainthenet.com
Registrar URL: http://www.DomainTheNet.com
Updated Date: 2020-12-03T12:21:33Z
Creation Date: 2007-12-31T12:58:31Z
Registry Expiry Date: 2022-12-31T12:58:31Z
Registrar: Domain The Net Technologies Ltd.
Registrar IANA ID: 10007
Registrar Abuse Contact Email: abuse@dtnt.com
Registrar Abuse Contact Phone: 972-3-7600500
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS.NETVISION.NET.IL
Name Server: NYPOP.NETVISION.NET.IL
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-17T09:02:21Z <<<

Copyright © 2022 WebZZ.US 0.0231